Introduction
Endovascular embolization plays an important role in the treatment of vascular malformations of the head, neck, and spine, including arteriovenous malformations (AVMs) and dural arteriovenous fistulas (dAVFs), as well as traumatic arterial injuries of the cerebrocervical vasculature. [1] [2] [3] [4] [5] [6] In many of these instances, liquid embolic agents such as n-butyl cyanoacrylate (n-BCA) (Tru-Fill; Cordis, Miami Lakes, FL) and ethylene-vinyl alcohol copolymer (Onyx; Ev3, Irvine, CA) are utilized to achieve permanent occlusion or embolization of the target vessel(s). 1, 7 A potential drawback to the use of such agents is entrapment of the delivery microcatheter in the embolized arterial pedicle. [8] [9] [10] [11] [12] This in turn could lead to thromboembolic complications if the catheter is left in the body, or hemorrhage if the parent artery is injured during device extraction.
There has consequently been considerable interest in the development of detachable-tip microcatheters, which feature a break point in their distal aspect allowing for separation of the device tip if it becomes entrapped in a liquid embolic cast. Two such catheters currently utilized in clinical practice are the SONIC (Balt, Montmorency, France) and Apollo Onyx Delivery (Ev3) microcatheters. However, only Apollo is currently approved for use in the United States (US) and features distal detachable tip lengths of 15 and 30 mm. While the safety and efficacy of the SONIC microcatheter have been previously described, there is a relative paucity of reports in the literature investigating the use of Apollo. [13] [14] [15] [16] [17] We therefore elected to report our initial experience with Apollo during all trans-arterial Onyx embolizations performed in the head, neck, and spine at our institution.
Materials and methods
The institutional review board approved the research protocol for this single-center, Health Insurance Portability and Accountability Act-compliant study. From a retrospective review of relevant radiology reports, we identified all procedures utilizing the Apollo Microcatheter for Onyx embolizations in the head, neck, and spine from its introduction at our institution in July 2014 to the time of data acquisition in August 2016. As our institution was taking part in the prospective Apollo Onyx Delivery Micro Catheter Post Market Safety Study, any procedure involving patients who were enrolled or deemed eligible for enrollment in this prospective study since our site activation were excluded from analysis (n ¼ 1). There were no other exclusion criteria.
Data acquisition
Data were obtained from multiple sources. Patient demographics, diagnoses, clinical outcomes, as well as procedural details, including arterial pedicles embolized, Apollo tip length selected, and intraprocedural complications, were acquired from procedure reports and the electronic medical record. Vessel caliber, reflux length, pedicle embolization time, and information regarding tip detachment were obtained by a review of relevant angiographic imaging. Vessel caliber was measured near the microcatheter tip on the most perpendicular two-dimensional (2D) digital subtraction angiography (DSA) image available, using the microcatheter detachment marker for calibration. Reflux length was measured on the last image obtained prior to microcatheter retrieval in a similar fashion. When patient follow-up information was available, the relevant clinical information and imaging were reviewed for any evidence of adverse delayed events as well as for lesion recurrence.
Procedure
All procedures were performed by one of three neurointerventional radiologists (DG, GJ, TRM) under general endotracheal anesthesia using one of two biplane flat-panel angiographic systems (Siemens Artis, Erlangen, Germany). While some procedures were performed using a short 6F sheath placed in the common femoral artery and a 6F guide catheter (Envoy, Cordis, Miami Lakes, FL), others with tortuous parent anatomy employed a 6F shuttle sheath and a distal access catheter, such as a 058 Navien (Ev3-Covidien, Irvine, CA). Once the guide/distal access catheter was placed in the parent artery, 2D as well as often three-dimensional rotational DSA imaging was performed to evaluate the relevant vascular anatomy. Occasionally, flat-panel dynamic rotation angiography was performed via the parent vessel to better evaluate the vascular anatomy in relation to surrounding bone and soft tissues. Once the pertinent imaging was performed, the Apollo microcatheter was advanced over a 0.010-or 0.008-inch microwire (Chikai 10, Asahi Intecc, Nagoya, Japan; Mirage 0.008, Ev3) and into the distal target pedicle using the biplane roadmap technique.
Onyx embolization was then performed through the microcatheter utilizing either Onyx 18, 34, or a combination of both, depending on the lesion and arterial pedicle utilized. In a subset of pedicle embolizations, a second, non-detachable microcatheter was initially utilized to form a ''plug'' of liquid embolic material around the slightly more distally positioned Apollo microcatheter. The proximal microcatheter was removed after formation of the plug, followed by the primary embolization performed via Apollo. This dualmicrocatheter technique was utilized to promote better forward penetration of the liquid embolic agent by the early formation of a robust proximal plug of material around the Apollo microcatheter.
After the desirable embolization was achieved, tension was gently applied to the Apollo microcatheter until the device either released from the liquid embolic cast or tip detachment occurred. Angiography was performed following microcatheter withdrawal to assess the results of embolization as well as to identify any complications. For vascular malformations not undergoing subsequent surgical or stereotactic radiosurgery treatment, follow-up angiography, and/or repeat embolization was typically performed within three to six months, depending on the results of the first session. Follow-up imaging was typically not performed for other indications.
Statistical analysis
Statistical analysis was performed using R (https:// www.r-project.org/) or Stata 11.2 (StataCorp LLC, College Station, TX). The primary outcome variable was whether the distal microcatheter tip successfully detached in the liquid embolic cast upon device removal (yes/no). For univariate analysis, the Fisher exact test was used to evaluate the association between a categorical covariate and microcatheter tip detachment, and the Student t test was used to assess a continuous variable and microcatheter tip detachment. A value of p < 0.05 was considered statistically significant. Logistic regression was used for multivariate analysis. In the regression model, microcatheter tip detachment was the dependent variable, and other covariates were potential predictors.
Results
A total of 58 arterial pedicle Onyx embolizations in 37 patients were performed in the head, neck, and spine using the Apollo Onyx Delivery Microcatheter at our institution during the study period. In the majority of pedicle embolizations, a 30 mm detachable-tip Apollo was utilized (n ¼ 43; 74%). Seven patients underwent more than one Onyx embolization procedure using Apollo during the study period (range 2-3), while two pedicle embolizations were performed in the same procedure in 10 instances (average 1.17 pedicle embolizations per procedure in the cohort). A dualmicrocatheter technique was utilized in seven pedicle embolizations. The majority of Apollo pedicle embolizations were performed for the treatment of cranial dAVFs (n ¼ 34) and cerebral AVMs (n ¼ 13), although less frequent indications included spinal dAVFs and AVMs (n ¼ 4), neck and face vascular malformations (n ¼ 3), pre-operative tumor embolization (n ¼ 2), and traumatic pseudoaneurysm (n ¼ 1) ( Table 1) .
The Apollo microcatheter was successfully navigated into the target pedicle in 57 of 58 pedicle catheterizations (98%). In the remaining instance, the Apollo microcatheter could not be navigated to a position where liquid embolization could safely be performed for treatment of a cranial dAVF due to pedicle tortuosity. There were no technical complications associated with the use of Apollo in this instance, and the case was subsequently excluded from further analysis. Pedicles utilized for embolization included branches of the external carotid artery (n ¼ 35), intracranial pial branches (n ¼ 12), aortic segmental arteries (n ¼ 5), the posterior meningeal artery (n ¼ 4), as well as branches of the subclavian artery/cervical vertebral artery (n ¼ 2). The average vessel pedicle caliber utilized for embolization was 1.5 mm (range 0.4-3.5 mm.).
The distal microcatheter tip detached in the liquid embolic cast upon device removal in 42 instances (73.7%) ( Table 2 ). There were no cases of microcatheter entrapment, early/inadvertent tip detachment, or pedicle injury upon removal of the microcatheter. However, there were two instances of a small amount of leakage of liquid embolic agent from the microcatheter detachment site (3.5%) during embolization. One occurred during treatment of a spinal dAVF via an aortic segmental artery, while the other involved treatment of an intracranial dAVF via a middle meningeal artery pedicle (Figure 1) . In both instances, the leakage was promptly detected and the detachment zone was located well within the target pedicle. Consequently, neither event resulted in non-target embolization or clinical sequelae. However, the spinal dAVF had to be subsequently treated with microsurgical repair because of early termination of Onyx embolization. In the case of the dAVF, the lesion was successfully obliterated by embolization performed via the contralateral middle meningeal artery.
Clinical outcomes in the cohort were overall excellent. In 18 patients treated for cranial dAVF, all but two were successfully cured by endovascular therapy alone. Five required more than one endovascular treatment procedure (range 1-3). Of the remaining two patients, one was successfully treated by a combined endovascular and surgical approach, while the other had a small residual fistula at the end of the procedure and was subsequently lost to follow-up. In 10 patients treated for cerebral AVMs and/or flow-related aneurysms, all procedures achieved their clinical goal. In five procedures, a target aneurysm was closed, while there was a significant reduction in size of the AVM nidus in the remaining five patients, who were subsequently treated either by stereotactic radiosurgery or surgical resection. In three patients treated for spinal vascular malformations, one spinal dAVF was cured by endovascular means alone, another required a combined endovascular and surgical approach, while the third patient with a spinal AVM had complete closure of the targeted arterial feeder and associated aneurysms. Finally, all cases of treatment of neck and face vascular malformations (n ¼ 3), preoperative tumor embolization (2), and pseudoaneurysm (n ¼ 1) were successful in lesion closure or reduction in lesion blood supply. In univariate analysis, length of Onyx reflux along the microcatheter tip and embolization time were significantly associated with microcatheter tip detachment (p < 0.001 and p ¼ 0.043, respectively). The mean length of Onyx reflux in cases with tip detachment compared to those for which the tip remained intact was 19.5 mm versus 7 mm. Furthermore, embolizations performed in external carotid artery braches were significantly associated with tip detachment compared to those performed in other vessel types (pial, spinal, vertebral branch) (p ¼ 0.0007). There was no significant association between tip detachment and other variables, including the use of dual-catheter technique, pedicle size, and type of Onyx used for embolization. In multivariate analysis, length of reflux of Onyx along the microcatheter tip and type of Onyx were significantly associated with tip detachment (Table 3) .
Overall, there were no instances of procedure-related permanent neurologic disability or mortality in the cohort. One patient treated for a cranial dAVF had a venous infarct with associated intraparenchymal hemorrhage the day following the procedure due to progressive thrombosis in a large, venous varix. The patient experienced temporary contralateral arm and leg weakness as well as neglect, which subsequently completely resolved. The patient later underwent a successful second embolization for recurrence of the same fistula without incident.
Discussion
Despite US Food and Drug Administration approval of the Apollo detachable tip microcatheter in 2014, only a few reports have been published investigating its use in clinical practice. In one of the larger studies to date, Altschul et al. 13 found Apollo to be both safe and effective for the embolization of pediatric brain AVMs using both n-BCA (n ¼ 16) as well as Onyx (n ¼ 11). Herial et al.
14 noted similar favorable results with Apollo during treatment of adult brain AVMs (n ¼ 7 pedicles). Our study differs significantly from these prior reports in that we report on a larger number of pedicle embolizations in a more diverse patient cohort. This latter feature also differentiates our study from the ongoing prospective Apollo Onyx Delivery Micro Catheter Post Market Safety Study, which aims to evaluate the safety of the device during embolization of brain AVMs in clinically stable patients. In contradistinction, the large majority of our patients were treated for either cranial dAVFs, or high-risk AVM features associated with acute hemorrhage, such as distal arterial pedicle or intranidal aneurysms. None of the patients in our cohort were eligible for this prospective study, and therefore represent a distinct patient population.
Our study demonstrates that the Apollo microcatheter is both safe and effective in a variety of neurointerventional procedures. Nearly all embolizations in the cohort achieved their clinical goal, whether that was occlusion of part or all of the target lesion, or reduction in blood flow prior to definitive treatment. Although most cranial dAVFs required more than one embolization procedure to achieve closure, it is noteworthy that the majority were complex lesions with numerous arterial feeders arising from multiple parent vessels. In fact, we found Apollo to be particularly well suited for treatment of these lesions, as they often require long embolization times with extensive Onyx reflux along the microcatheter tip to achieve adequate lesion penetration. A detachable-tip microcatheter is highly desirable in this setting. The preponderance of dAVF cases in the cohort may explain, at least in part, the high rate of microcatheter tip detachment in our study (73.7% for entire cohort, 82% for embolizations of dAVFs) compared to prior investigations (9-43%). 13, 14 We experienced two technical complications associated with the use of Apollo. In both instances, there was a small amount of leakage of Onyx from the detachment site during embolization, which did not result in any adverse sequelae. In one case, leakage occurred following a relatively prolonged pause (approximately 90 to 120 seconds) during embolization of a spinal dAVF that was performed due to excessive proximal Onyx reflux. This may have resulted in occlusion of the distal aspect of the microcatheter, which in turn precipitated the proximal leakage. As a result of these cases, we recommend performing embolization with Apollo only when the detachment site can be well situated in the target pedicle, away from parent vessels potentially supplying eloquent cerebrovascular territory. Moreover, it is now our practice to always include the proximal detachment marker within the field of view during embolization so that we may monitor the site for any leakage of liquid embolic agent.
There were no instances of microcatheter entrapment in the cohort, and, unlike prior reports detailing the use of SONIC, there were no cases of premature tip detachment. 16, 17 The one instance of procedure-related neurologic morbidity in the cohort involved a hemorrhagic venous infarct that developed following embolization of a cranial dAVF with progressive thrombosis of a draining large venous varix. We believe that the use of Apollo in this case did not play a significant role in the development of the complication, and the patient made a full neurologic recovery. Finally, despite possible concerns regarding the navigability of the distal tip of the device, there was only a single instance in our cohort in which pedicle catheterization was unsuccessful because of vessel tortuosity.
We found that length of Onyx reflux, embolization in external carotid artery pedicles, as well as longer embolization times were associated with microcatheter tip detachment in univariate analysis. In multivariate analysis, tip detachment was associated with the length of Onyx reflux as well as the use of Onyx 34 (alone or with Onyx 18). Our study shows that the length of Onyx reflux is the main factor determining tip detachment, while other variables, including embolization time, pedicle type, two-microcatheter technique, Apollo tip length, and pedicle size, were not significant. We purposefully did not evaluate pedicle tortuosity in the current study owing to the difficulty in objectively determining this metric, though it is plausible that arterial tortuosity may influence the rate of microcatheter tip detachment. Finally, the influence of Onyx type on tip detachment is somewhat more surprising, but may be related to the greater viscosity of Onyx 34.
Our study has several limitations, the most significant of which is its retrospective design. Furthermore, although we view the diversity of neuroembolization procedures included in the study as a strength, the variety of cases limits our ability to evaluate the performance of Apollo in specific clinical scenarios (e.g. embolization of spinal vascular malformations).
Finally, routine imaging follow-up of retained microcatheter tips was not performed, so our study does not address possible delayed adverse sequelae associated with tip retention. However, this issue should be addressed by the ongoing prospective safety study. Despite these concerns, we believe our results demonstrate Apollo to be highly safe and efficacious for all relevant neuroembolization procedures.
Conclusions
The use of the Apollo microcatheter is both safe and effective during neurointerventional embolizations utilizing ethylene-vinyl alcohol copolymer. Leakage of liquid embolic agent from the detachment site is an infrequent technical complication that may be encountered with the device. The detachment site therefore should be monitored throughout embolization, and be well situated in the target pedicle, away from parent vessels potentially supplying eloquent cerebrovascular territory.
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